Literature DB >> 892335

Serum glycoproteins in the liver diseases. IV. Alpha-1 acid glycoprotein level in liver cirrhosis.

T Arima, Y Motoyama, T Yamamoto, K Nagata, T Kondo.   

Abstract

Circulating alpha-1 acid glycoprotein level in cirrhotic patients was determined by radioimmunoassay, and was compared to the ones in normal subjects and chronic active hepatitis with sublobular necrosis. Serum alpha-1 acid glycoprotein levels in liver cirrhosis (p less than 0.001) and chronic active hepatitis with sublobular necrosis (p less than 0.02) were significantly reduced comparing to the normal subjects, although any statistically significant difference was not observed between the formers. In liver cirrhosis, thie serum alpha-1 acid glycoprotein level correlated negatively with serum albumin concentration but neither with serum alpha-1 globulin fraction nor with Indocyanine green clearance rate.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 892335     DOI: 10.1007/bf02773624

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  9 in total

1.  Survey of clinical significance of serum mucoprotein level.

Authors:  E M GREENSPAN
Journal:  AMA Arch Intern Med       Date:  1954-06

Review 2.  The role of surface carbohydrates in the hepatic recognition and transport of circulating glycoproteins.

Authors:  G Ashwell; A G Morell
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1974

Review 3.  On the biological role of glycoproteins.

Authors:  E H Eylar
Journal:  J Theor Biol       Date:  1966-01       Impact factor: 2.691

4.  The metabolism of plasma glycoproteins. I. Studies on the rate of incorporation of glucosamine-1-14C into protein-bound hexosamine and N-acetylneuraminic acid in the normal rat.

Authors:  R A Macbeth; J G Bekesi; E Sugden; S Bice
Journal:  J Biol Chem       Date:  1965-10       Impact factor: 5.157

5.  Serum glycoproteins in the liver diseases. II. Radioimmunoassay of alpha-1 acid glycoprotein.

Authors:  T Arima; Y Motoyama; K Nagata; T Kondo
Journal:  Gastroenterol Jpn       Date:  1976

6.  Measurement of circulating desialylated glycoproteins and correlation with hepatocellular damage.

Authors:  J S Marshall; A M Green; J Pensky; S Williams; A Zinn; D M Carlson
Journal:  J Clin Invest       Date:  1974-09       Impact factor: 14.808

7.  Albumin synthesis in cirrhotic subjects with ascites studied with carbonate-14C.

Authors:  M A Rothschild; M Oratz; D Zimmon; S S Schreiber; I Weiner; A Van Caneghem
Journal:  J Clin Invest       Date:  1969-02       Impact factor: 14.808

8.  Orosomucoid content of pleural and peritoneal effusions.

Authors:  D Rudman; R K Chawla; A E Del Rio; B M Hollins; E C Hall; J M Conn
Journal:  J Clin Invest       Date:  1974-07       Impact factor: 14.808

9.  Studies on the mucoproteins of human plasma; plasma mucoprotein levels in cancer patients.

Authors:  R J WINZLER; I M SMYTH
Journal:  J Clin Invest       Date:  1948-09       Impact factor: 14.808

  9 in total
  2 in total

1.  Ricinus communis agglutinin II-reactive glycoproteins from the ascites of patients with hepatocellular carcinoma and their use in enzyme-linked immunosorbent assay.

Authors:  M Fukushima; T Arima; H Nagashima
Journal:  Gastroenterol Jpn       Date:  1987-04

2.  Serum glycoproteins in the liver diseases. VIII. Desialylated glycoproteins in the liver cirrhosis.

Authors:  T Arima
Journal:  Gastroenterol Jpn       Date:  1979-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.